Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma

被引:40
|
作者
Kim, H
Lee, MJ
Rim, MR
Chung, IP
Kim, YM
Lee, JY
Jang, JJ
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea
[2] Catholic Univ, Coll Med, Dept Pathol, Seoul, South Korea
[3] Catholic Univ, Coll Med, Inst Canc Res, Seoul, South Korea
来源
LIVER | 2000年 / 20卷 / 02期
关键词
hepatocellular carcinoma; childhood; cyclin D1; 13q; loss of heterozygosity;
D O I
10.1034/j.1600-0676.2000.020002173.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims/Background: In hepatitis B virus-related hepatocellular carcinoma(HCC), at least 20-40 years of continuous necro-inflammation is necessary for the hepato-carcinogenesis to occur. However, HCC in childhood shows an unusually short latent period and rapid progression. In our previous report, mutation of c-met was found only in childhood HCC, but not in adult HCC. In order to determine the specific biological tumorous features of childhood HCC, a comparison study of childhood and adult HCC was performed. Methods: Eighteen cases of HBV positive HCC (nine children and nine adults aged more than 40 years) were selected. The expression of G1 phase regulatory proteins (cyclin D1, cyclin E and cdk4) was studied using immunohistochemical methods. Loss of heterozygosity (LOH) on chromosomal arms 8p, 13q and 17p was analyzed. Results: Cyclin D1 expression was significantly lower in childhood HCC than in adult HCC (cases of cyclin D1 expression under 3+: childhood 5/9 vs. adult 1/9, p=0.046). No difference in cyclin E and cdk4 expression was found between childhood and adult HCC. LOH frequency on 13q was relatively higher in childhood than in adult HCC (66.7% vs. 2.2%, p=0.058). LOH frequency on sp and 17p was 44.4% and 33.3% in childhood HCC and 44.4% and 75% in adult HCC with no statistical significance between the two groups. Conclusion: Our data suggest that childhood HCC may be less dependent on cyclin D1 protein for tumor growth and progression than adult HCC, and that the LOH on 13q may be an important feature of childhood HCC.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条
  • [1] Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
    Jeng-Wei Lu
    Yueh-Min Lin
    Jan-Gowth Chang
    Kun-Tu Yeh
    Rong-Ming Chen
    Jeffrey J. P. Tsai
    Wei-Wen Su
    Rouh-Mei Hu
    Medical Oncology, 2013, 30
  • [2] Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
    Lu, Jeng-Wei
    Lin, Yueh-Min
    Chang, Jan-Gowth
    Yeh, Kun-Tu
    Chen, Rong-Ming
    Tsai, Jeffrey J. P.
    Su, Wei-Wen
    Hu, Rouh-Mei
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [3] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    Matsumoto, M
    Furihata, M
    Ishikawa, T
    Ohtsuki, Y
    Ogoshi, S
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 256 - 261
  • [4] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    M Matsumoto
    M Furihata
    T Ishikawa
    Y Ohtsuki
    S Ogoshi
    British Journal of Cancer, 1999, 80 : 256 - 261
  • [5] Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome
    Sengelov, L
    Christensen, M
    von der Maase, H
    Horn, T
    Marcussen, N
    Kamby, C
    Orntoft, T
    CANCER GENETICS AND CYTOGENETICS, 2000, 123 (02) : 109 - 113
  • [6] ALLELOTYPING OF DUCTAL CARCINOMA IN-SITU OF THE BREAST - DELETION OF LOCI ON 8P, 13Q, 16Q, 17P AND 17Q
    RADFORD, DM
    FAIR, KL
    PHILLIPS, NJ
    RITTER, JH
    STEINBRUECK, T
    HOLT, MS
    DONISKELLER, H
    CANCER RESEARCH, 1995, 55 (15) : 3399 - 3405
  • [7] ACCUMULATION OF ALLELIC LOSS ON ARMS OF CHROMOSOMES 13Q, 16Q AND 17P IN THE ADVANCED STAGES OF HUMAN HEPATOCELLULAR-CARCINOMA
    NISHIDA, N
    FUKUDA, Y
    KOKURYU, H
    SADAMOTO, T
    ISOWA, G
    HONDA, K
    YAMAOKA, Y
    IKENAGA, M
    IMURA, H
    ISHIZAKI, K
    INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (06) : 862 - 868
  • [8] Daidzein and Chicory Extract Arrest the Cell Cycle via Inhibition of Cyclin D/CDK4 and Cyclin A/CDK2 Gene Expression in Hepatocellular Carcinoma
    Abdel-Hamid, Nabil M.
    Zakaria, Sherin
    Nawaya, Reem A.
    Eldomany, Ramadan A.
    El-Shishtawy, Mamdouh M.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (02) : 187 - 199
  • [9] High frequency of loss of heterozygosity on chromosomes 1p, 4p, 4q, 9p, 13q, and 17p in hepatocellular carcinomas from Australia and South Africa.
    Herath, NI
    Kew, MC
    Young, JP
    Powell, LW
    Leggett, BA
    Macdonald, GA
    HEPATOLOGY, 2001, 34 (04) : 181A - 181A
  • [10] Losses of Chromosome Arms 4q, 8p, 13q and Gain of 8q Are Correlated with Increasing Chromosomal Instability in Hepatocellular Carcinoma
    Hertz, Sabine
    Rothaemel, Thomas
    Skawran, Britta
    Giere, Christian
    Steinemann, Doris
    Flemming, Peer
    Becker, Thomas
    Flik, Jacobus
    Wiese, Birgit
    Soudah, Bisharah
    Kreipe, Hans
    Schlegelberger, Brigitte
    Wilkens, Ludwig
    PATHOBIOLOGY, 2008, 75 (05) : 312 - 322